Friedenthal Financial Buys New Position in Omega Healthcare Investors, Inc. $OHI

Friedenthal Financial bought a new stake in shares of Omega Healthcare Investors, Inc. (NYSE:OHIFree Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 22,001 shares of the real estate investment trust’s stock, valued at approximately $964,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Resources Management Corp CT ADV lifted its stake in shares of Omega Healthcare Investors by 300.0% in the 4th quarter. Resources Management Corp CT ADV now owns 600 shares of the real estate investment trust’s stock worth $27,000 after acquiring an additional 450 shares during the period. Smartleaf Asset Management LLC boosted its holdings in shares of Omega Healthcare Investors by 40.9% in the second quarter. Smartleaf Asset Management LLC now owns 924 shares of the real estate investment trust’s stock valued at $34,000 after acquiring an additional 268 shares in the last quarter. Gunpowder Capital Management LLC dba Oliver Wealth Management acquired a new position in shares of Omega Healthcare Investors during the fourth quarter valued at approximately $37,000. Rothschild Investment LLC increased its stake in shares of Omega Healthcare Investors by 283.7% during the fourth quarter. Rothschild Investment LLC now owns 944 shares of the real estate investment trust’s stock valued at $42,000 after acquiring an additional 698 shares during the period. Finally, Larson Financial Group LLC raised its holdings in Omega Healthcare Investors by 345.2% during the fourth quarter. Larson Financial Group LLC now owns 984 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 763 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors.

Omega Healthcare Investors Trading Up 2.2%

NYSE:OHI opened at $47.41 on Thursday. The stock has a fifty day simple moving average of $46.39 and a 200 day simple moving average of $45.72. The firm has a market capitalization of $14.12 billion, a price-to-earnings ratio of 22.90, a price-to-earnings-growth ratio of 1.98 and a beta of 0.58. Omega Healthcare Investors, Inc. has a 1-year low of $35.70 and a 1-year high of $49.33. The company has a quick ratio of 5.32, a current ratio of 5.32 and a debt-to-equity ratio of 0.81.

Omega Healthcare Investors (NYSE:OHIGet Free Report) last posted its quarterly earnings data on Tuesday, April 28th. The real estate investment trust reported $0.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.49 by ($0.02). Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The company had revenue of $322.95 million for the quarter, compared to analyst estimates of $264.07 million. During the same quarter in the previous year, the firm posted $0.75 EPS. Omega Healthcare Investors’s quarterly revenue was up 16.7% on a year-over-year basis. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Sell-side analysts forecast that Omega Healthcare Investors, Inc. will post 3.1 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, May 4th were given a $0.67 dividend. This represents a $2.68 annualized dividend and a dividend yield of 5.7%. The ex-dividend date of this dividend was Monday, May 4th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 129.47%.

Analyst Ratings Changes

OHI has been the subject of a number of research analyst reports. Royal Bank Of Canada upped their target price on Omega Healthcare Investors from $47.00 to $48.00 and gave the stock a “sector perform” rating in a research report on Monday, May 4th. UBS Group set a $47.00 price target on Omega Healthcare Investors in a research report on Thursday, June 18th. Scotiabank dropped their price objective on Omega Healthcare Investors from $50.00 to $47.00 and set a “sector perform” rating on the stock in a research note on Thursday, June 18th. Bank of America restated an “underperform” rating and issued a $46.00 price objective (down from $52.00) on shares of Omega Healthcare Investors in a report on Tuesday, April 14th. Finally, Truist Financial decreased their target price on Omega Healthcare Investors from $48.00 to $46.00 and set a “hold” rating for the company in a research note on Tuesday, June 9th. Five equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $48.31.

Check Out Our Latest Research Report on OHI

Omega Healthcare Investors Profile

(Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.

Recommended Stories

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHIFree Report).

Institutional Ownership by Quarter for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.